Physician profile
Eric Kruger
NPI 1487634952
$404.14
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2021: $12.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $78.67 | 2019 | |
| Astellas Pharma US INC | $57.49 | 2019 | |
| Lilly USA, LLC | $37.72 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.52 | 2019 | |
| Currax Pharmaceuticals LLC | $25.94 | 2019 | |
| Amarin Pharma, INC. | $24.33 | 2019 | |
| Neotract INC. | $21.94 | 2019 | |
| Allergan, INC. | $21.71 | 2019 | |
| Strongbridge US INC. | $14.90 | 2019 | |
| Mannkind Corporation | $14.57 | 2019 | |
| Amgen INC. | $14.17 | 2019 | |
| Glaxosmithkline, LLC. | $13.63 | 2019 | |
| Sunovion Pharmaceuticals INC. | $13.26 | 2019 | |
| Merck Sharp & Dohme LLC | $13.07 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.67 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kruger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.